Difference between revisions of "Tocilizumab (Actemra)"
Jump to navigation
Jump to search
m |
Warner-admin (talk | contribs) m (Text replacement - "Category:Antibody medications" to "") |
||
| Line 13: | Line 13: | ||
[[Category:Drugs]] | [[Category:Drugs]] | ||
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
| − | + | ||
[[Category:Anti-IL-6R antibodies]] | [[Category:Anti-IL-6R antibodies]] | ||
Revision as of 19:36, 27 February 2020
Mechanism of action
Monoclonal antibody directed against the IL-6 receptor
Diseases for which it is used
History of changes in FDA indication
- 1/8/2010: Initial FDA approval for rheumatoid arthritis
Also known as
- Brand name: Actemra